Spots Global Cancer Trial Database for therapeutic autologous dendritic cells
Every month we try and update this database with for therapeutic autologous dendritic cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | NCT00266110 | Breast Cancer | sargramostim therapeutic aut... trastuzumab vinorelbine dit... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00085397 | Melanoma (Skin) | autologous dend... gp100 antigen therapeutic aut... | - | National Cancer Institute (NCI) | |
| APC8015 and Bevacizumab in Treating Patients With Prostate Cancer | NCT00027599 | Prostate Cancer | bevacizumab prostatic acid ... sipuleucel-T therapeutic aut... in vitro-treate... | - | National Cancer Institute (NCI) | |
| Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery | NCT03325101 | Stage III Cutan... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... | Cryosurgery Pembrolizumab Pheresis Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| p53 Vaccine for Ovarian Cancer | NCT00001827 | Ovarian Neoplas... | aldesleukin incomplete Freu... p53 peptide vac... sargramostim therapeutic aut... in vitro-treate... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia | NCT00100971 | Leukemia | autologous tumo... therapeutic aut... tumor cell-deri... | 18 Years - | Boston Medical Center | |
| Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma | NCT00436930 | Melanoma (Skin) | autologous tumo... sargramostim therapeutic aut... | 16 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer | NCT00103142 | Colorectal Canc... Metastatic Canc... | falimarev inalimarev sargramostim therapeutic aut... | 18 Years - | Duke University | |
| Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery | NCT03325101 | Stage III Cutan... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... | Cryosurgery Pembrolizumab Pheresis Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | NCT00088985 | Breast Cancer | therapeutic aut... trastuzumab vinorelbine dit... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma | NCT00012064 | Melanoma (Skin) | therapeutic aut... | 16 Years - | Lisata Therapeutics, Inc. | |
| Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | NCT00093522 | Kidney Cancer | autologous tumo... keyhole limpet ... therapeutic aut... fludarabine pho... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00639639 | Malignant Neopl... | tetanus toxoid therapeutic aut... therapeutic aut... | 18 Years - | Duke University | |
| Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer | NCT01826877 | Clear Cell Rena... Recurrent Renal... Stage IV Renal ... | AdGMCAIX-transd... therapeutic aut... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) | NCT00499083 | Breast Cancer | therapeutic aut... aromatase inhib... cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... gene expression... protein express... reverse transcr... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... radiation thera... | 19 Years - 120 Years | University of Nebraska | |
| Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer | NCT00103142 | Colorectal Canc... Metastatic Canc... | falimarev inalimarev sargramostim therapeutic aut... | 18 Years - | Duke University | |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005992 | Prostate Cancer | PSA prostate ca... therapeutic aut... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00023985 | Lung Cancer | autologous tumo... therapeutic aut... conventional su... | 18 Years - 75 Years | Roswell Park Cancer Institute | |
| Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00006113 | Melanoma (Skin) | MART-1 antigen aldesleukin gp100 antigen recombinant CD4... recombinant int... recombinant int... sargramostim therapeutic aut... therapeutic tum... tyrosinase pept... Candida albican... | 18 Years - | University of Southern California | |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma | NCT00126685 | Melanoma (Skin) | autologous tumo... therapeutic aut... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast | NCT00107211 | Breast Cancer | therapeutic aut... conventional su... neoadjuvant the... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer | NCT00814892 | Prostate Cancer | allogeneic tumo... therapeutic aut... | 18 Years - | Mayo Clinic | |
| A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas | NCT00001566 | Ewing's Sarcoma Rhabdomyosarcom... | therapeutic aut... indinavir sulfa... peripheral bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | NCT00093522 | Kidney Cancer | autologous tumo... keyhole limpet ... therapeutic aut... fludarabine pho... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC) | NCT05518032 | Metastatic Micr... Recurrent Color... Stage III Color... Stage IV Colore... Unresectable Co... | Biopsy Pembrolizumab Therapeutic Aut... | 18 Years - | Roswell Park Cancer Institute | |
| Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer | NCT03942328 | Stage III Hepat... Stage III Intra... Stage IV Hepato... Stage IV Intrah... Unresectable He... Unresectable In... | Atezolizumab Bevacizumab External Beam R... Pheresis Pneumococcal 13... Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00010127 | Prostate Cancer | therapeutic aut... | 18 Years - | Duke University | |
| Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery | NCT03325101 | Stage III Cutan... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... | Cryosurgery Pembrolizumab Pheresis Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma | NCT00107185 | Brain and Centr... | therapeutic aut... | 1 Year - 18 Years | Jonsson Comprehensive Cancer Center | |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00053391 | Melanoma (Skin) | recombinant CD4... therapeutic aut... | 18 Years - | University Hospital Erlangen | |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00085488 | Melanoma (Skin) | autologous tumo... therapeutic aut... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission | NCT00963521 | Leukemia | therapeutic aut... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00639639 | Malignant Neopl... | tetanus toxoid therapeutic aut... therapeutic aut... | 18 Years - | Duke University | |
| Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00023985 | Lung Cancer | autologous tumo... therapeutic aut... conventional su... | 18 Years - 75 Years | Roswell Park Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
